Details of the Drug

General Information of Drug (ID: DM9XV3C)

Drug Name
LymPro
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 2 [1]
Cross-matching ID
TTD ID
D0H1YZ

References

1 Amarantus BioScience Licenses LymPro Alzheimer's Disease Diagnostic Blood Test